The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic role of baseline levels and early changes of systemic inflammatory indexes for avelumab maintenance in metastatic urothelial carcinoma: The Meet-URO25a/SAILOR study.
 
Brigida Anna Maiorano
Research Funding - Merck
Travel, Accommodations, Expenses - Ipsen; Janssen; Novartis; Pfizer
 
Marco Maruzzo
No Relationships to Disclose
 
Pierangela Sepe
No Relationships to Disclose
 
Martina Fanelli
No Relationships to Disclose
 
Antonello Veccia
No Relationships to Disclose
 
Roberto Filippi
No Relationships to Disclose
 
Alessia Cavo
No Relationships to Disclose
 
Marco Pisino
No Relationships to Disclose
 
Antonio Doronzo
No Relationships to Disclose
 
Michele Dionese
No Relationships to Disclose
 
Simona Secondino
No Relationships to Disclose
 
Francesca Vignani
No Relationships to Disclose
 
Valentina Guadalupi
No Relationships to Disclose
 
Federico Paolieri
No Relationships to Disclose
 
Maria Cossu Rocca
No Relationships to Disclose
 
Daniele Galanti
No Relationships to Disclose
 
Palma Fedele
No Relationships to Disclose
 
Michela Roberto
No Relationships to Disclose
 
Lorenzo Antonuzzo
Honoraria - Amgen; AstraZeneca; Novartis; Roche
Consulting or Advisory Role - Merck Serono; MSD Oncology
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Consulting or Advisory Role - AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Catalym; Genenta Science; Gilead Sciences; Incyte; Johnson & Johnson/Janssen; Merck Serono; Merck Sharp & Dohme; Peerview; PeerVoice; Samsung Bioepis; Seattle Genetics/Astellas
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Gilead Sciences (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Janssen; Merck Sharp & Dohme